EVOKE PHARMA, INC. Stock Split Ratio
EVOKE PHARMA, INC. reported Stock Split Ratio of 75.00% for the 6-month period ending 2019-06-30, per its 10-K filed 2021-03-11.
Discontinued › Notes › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2021-03-11
- 2019-06-30: Stockholders' Equity Note, Stock Split, Conversion Ratio 6 month 75.00%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio 6 month |
|---|---|
| 2019-06-30 | 75.00% 10-K · filed 2021-03-11 |